Abstract:Objective\r\nIt is well known that the suppression of gastric acidity is one of the most essential factors in promoting healing and preventing relapse of peptic ulcers. Little is known, however, about how to inhibit gastric acid secretion effectively in children with peptic ulcers. The present study aimed at understanding the optimal acid suppression by examining the relationship between ulcer healing and the suppression of gastric acid in children.\r\n\r\n\r\nMethods\r\nPatients with peptic ulcers diagnosed by endoscopy were randomized to receive either oral ranitidine (group A) or oral omeprazole (group B) for 4-6 weeks (mean 5 weeks) . Intragastric 24-hour pH monitoring was performed before treatment, and repeated three times: on day 1, weeks 1 and 5 post-dosing. Endoscopy was repeated on week 5 to evaluate the healing condition of ulcers.\r\n\r\n\r\nResults\r\nTwenty-seven patients followed up by endoscopy and pH monitoring were eligible for final analysis. The ulcers in 16 patients of group A and in all (11 cases) of group B were healed. No significant differences in the gastric mean pH, median pH and percentage of time with gastric pH \u003e 3 between the two groups were observed before treatment. Gastric pH increased significantly after treatment in both groups. These parameters in group A decreased significantly during weeks 1 and 5 as compared to those on day 1 post-dosing; the duration of drug action was also shortened significantly. The gastric mean pH and mean median pH in group B were significantly higher during weeks 1 and 5than on day 1 of post-dosing, the duration of drug action was also prolonged significantly. According to the result of endoscopic re-examination, the authors subdivided group A into unhealed (group C) and healed (group D) groups. The gastric acid suppressive effect in group C attenuated significantly by the end of the 5-week treatment and the differences of gastric mean pH and median pH, percentage of time with pH \u003e 3 between week 5 and pre-treatment level were not significant. While these parameters in group D were still significantly higher during week 5than those obtained before treatment. The gastric mean pH and median pH, percentage of time with pH \u003e 3 and the duration of drug action during week 5 were significantly higher in group D than in group C. The mean shortest duration of drug action in group B was 10 h, while it was 5 h in group D.\r\n\r\n\r\nConclusions\r\nThe onset of tolerance to ranitidine during the therapy might have affected healing of ulcers in the subjects. The optimal acid suppression for healing ulcere in children could be regarded as maintaining the gastric pH \u003e 3 for 5-10 hours a day of post-dosing during 4-6 weeks of anti-secretory treatment.\r\n\r\n\r\nKey words: \r\nPeptic ulcer; Hydrogen-ion concentration; Ranitidine; Omeprazole; Drug tolerance

Effect of Omeprazole in treating peptic ulcers of children

Optimal suppression of gastric acid and ulcer healing in children with peptic ulcer

Long-term Therapeutic Effect of Triple Therapy Consisted of Omeperazole,clarithromycin and Amoxycillin in Children with Helicobacter Pylori Infection and Approach to Re-Treatment after Failure of the Treatment

The Effect of Low-Dose Omeprazole on 24-Hour Intragastric Ph in Healthy Human Subjects

The Symptomatic Improvement and Safety of Rabeprazole on Peptic Ulcer

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-Positive Gastric Ulcer Patients after Eradication Therapy: A Randomized Double-Blind, Multinational, Multi-Institutional Comparative Study

Effect of omeprazole in treatment of peptic ulcer bleeding

[Clinical Effect of Triple Therapy Combined with Saccharomyces Boulardii in the Treatment of Helicobacter Pylori Infection in Children].

Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

Low-dose omeprazole in the treatment of functional dyspepsia

EFFICACY OF INTRAVENOUS ADMINISTRATION OF OMEPRAZOLEIN THE TREATMENT OF UPPER GASTROINTESTINAL HEMORRHAGE CAUSED BY PEPTIC ULCER AND ACUTE GASTRIC MUCOSAL LESION

Pharmacokinetics and 24-Hour Intragastric Ph Monitoring after Venous Infusion of Omeprazole in Healthy Subjects

Acid-suppressive Effects of Rabeprazole: Comparing 10mg and 20mg Twice Daily in Japanese Helicobacter Pylori-Negative and -Positive CYP2C19 Extensive Metabolisers

Clinical effect of combination of octreotide and omeprazole in children with acute upper gastrointestinal bleeding and the levels of serum creatinine and serum urea nitrogen

Evaluation of the Effect of Ilaprazole on Intragastrtc Ph in Patients with Duodenal Ulcer

Effect of microecological agents for eradication of Helicobacter pylori in children: A Meta analysis

Multi-center Clinical Study of Rabeprazole in the Treatment of Peptic Ulcer Clinical Study Group of Rabeprazole, Correspondence

Efficacy and Safety of Omeprazole for the Treatment of Acid Peptic Disorders: A Systematic Review and Meta-Analysis

Effect of rebamipide combined with famotidine in the treatment of active gastric ulcer in 61 patients

Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.

Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients